Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system (original) (raw)
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT
Luis Miguel
Lancet, 2000
View PDFchevron_right
Current Treatment of Patients with Hypertension
Stefano Taddei
Drugs, 2003
View PDFchevron_right
Calcium channel blockers and hypertension
Allegra Battistoni
Journal of cardiovascular pharmacology and therapeutics, 2015
View PDFchevron_right
Calcium antagonists: Not appropriate as first line antihypertensive agents
Curt Furberg
1996
View PDFchevron_right
The role of calcium channel blockers in the treatment of hypertension
Luigi Cubeddu
American Heart Journal, 1986
View PDFchevron_right
Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
Brian Zhang
View PDFchevron_right
Calcium antagonists, a useful additional therapy in treatment resistant hypertension: Comparison of felodipine ER and nifedipine Retard by 24-h ambulatory blood pressure monitoring
J.G.S. Breed
The Netherlands Journal of Medicine, 1997
View PDFchevron_right
Research advance in clinical evaluation of antihypertensive Drug
International Journal of Pharmaceutical Sciences
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES, 2024
View PDFchevron_right
Antihypertensive drugs: Issues beyond blood pressure control
Jonathan Pinkney
Progress in Cardiovascular Diseases, 1994
View PDFchevron_right
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension
Wille Oigman
The American Journal of Cardiology, 1983
View PDFchevron_right
Addition of chlorthalidone to slow-release nifedipine in the treatment of arterial hypertension: A controlled study versus placebo
Fabrizio Pasanisi
Cardiovascular Drugs and Therapy, 1988
View PDFchevron_right
Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study
Dhruvi Pandit
American journal of cardiovascular disease, 2021
View PDFchevron_right
Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, …
Carlos Campo
Journal of human …, 2004
View PDFchevron_right
Nifedipine in the treatment of hypertension: report of a double-blind controlled trial
S. Bayley
British Journal of Clinical Pharmacology, 1982
View PDFchevron_right
A Comparison of Fosinopril and Hydrochlorothiazide with Nifedipine SR in Patients with Mild to Moderate Hypertension
F. Plat
Clinical Drug Investigation, 1997
View PDFchevron_right
Long-term therapy with slow-release nifedipine in essential hypertension
Francesco Arrigo
Cardiovascular Drugs and Therapy, 1990
View PDFchevron_right
Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients
Kwo-chang Ueng
Clinical Drug Investigation, 2011
View PDFchevron_right
Efficacy and safety of ACT-280778, a dual L- and T-type calcium channel blocker, in patients with mild-to-moderate essential hypertension: results from a phase 2a, randomized, double-blind, placebo- and active-controlled trial (REDUCE–1)
Jasper Dingemanse
View PDFchevron_right
Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension
Jasper Dingemanse
Journal of human hypertension, 2015
View PDFchevron_right
Calcium-channel blockers and sodium intake: A controlled study in patients with essential hypertension
Francesco P Cappuccio
Cardiovascular Drugs and Therapy, 1989
View PDFchevron_right
Antihypertensive Drugs
H Babaei
2012
View PDFchevron_right
Comparison of different therapeutic strategies in hypertension
Gerard Duru
Journal of Hypertension, 2004
View PDFchevron_right
Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients
Carlos Campo
Journal of Human Hypertension, 2004
View PDFchevron_right
Current issues on the management of hypertension
CHU HEI LAU
1996
View PDFchevron_right
Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine
Maurizio Castellano
Journal of the American College of Cardiology, 1986
View PDFchevron_right
An update on the management of hypertension
Marise Gauci
2007
View PDFchevron_right
Hemodynamic study of nifedipine administration in hypertensive patients
Nicola Ferrara
American Heart Journal, 1983
View PDFchevron_right
Drugs in the management of hypertension. Part I
Henry Yager
American Heart Journal, 1976
View PDFchevron_right
Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association
Tzung-dau Wang
Hypertension Research, 2011
View PDFchevron_right
The antihypertensive efficacy of the novel calcium antagonist mibefradil in comparison with nifedipine GITS in moderate to severe hypertensives with ambulatory hypertension
Luc Poirier
American Journal of Hypertension, 1997
View PDFchevron_right
Current antihypertensive treatment: can we do better?
Cristina Giannattasio
American journal of hypertension, 1999
View PDFchevron_right
Ambulatory Blood Pressures in Hypertensive Patients Treated With One Antihypertensive Agent: Differences Among Drug Classes and Among Drugs Belonging to the Same Class
Manuel Gorostidi
Journal of clinical hypertension (Greenwich, Conn.), 2015
View PDFchevron_right
A Summary of the Effects of Antihypertensive Medications on Measured Blood Pressure
R Aldy
American Journal of Hypertension, 2005
View PDFchevron_right
A Review On: Pharmacotherapy of Hypertension
Aniket Bankar
2022
View PDFchevron_right
The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension
Bernd Mühlbauer
Journal of Hypertension, 1995
View PDFchevron_right